Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer

Purpose. To investigate the expression of TSP50 protein in human gastric cancers and its correlation with clinical/prognostic significance. Methods. Immunohistochemistry (IHC) analysis of TSP50 was performed on a tissue microarray (TMA) containing 334 primary gastric cancers. Western blot was carri...

Full description

Saved in:
Bibliographic Details
Main Authors: Fang Liu, Qinghua Cao, Ni Liu, Changzhao Li, Changxuan You, Chuanxin Liu, Ling Xue, Rongcheng Luo
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2014/498246
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849695448916295680
author Fang Liu
Qinghua Cao
Ni Liu
Changzhao Li
Changxuan You
Chuanxin Liu
Ling Xue
Rongcheng Luo
author_facet Fang Liu
Qinghua Cao
Ni Liu
Changzhao Li
Changxuan You
Chuanxin Liu
Ling Xue
Rongcheng Luo
author_sort Fang Liu
collection DOAJ
description Purpose. To investigate the expression of TSP50 protein in human gastric cancers and its correlation with clinical/prognostic significance. Methods. Immunohistochemistry (IHC) analysis of TSP50 was performed on a tissue microarray (TMA) containing 334 primary gastric cancers. Western blot was carried out to confirm the expression of TSP50 in gastric cancers. Results. IHC analysis revealed high expression of TSP50 in 57.2% human gastric cancer samples (191 out of 334). However, it was poorly expressed in all of the 20 adjacent nontumor tissues. This was confirmed by western blot, which showed significantly higher levels of TSP50 expression in gastric cancer tissues than adjacent nontumor tissues. A significant association was found between high levels of TSP50 and clinicopathological characteristics including junior age at surgery (P=0.001), later TNM stage (P=0.000), and present lymph node metastases (P=0.003). The survival of gastric cancer patients with high expression of TSP50 was significantly shorter than that of the patients with low levels of TSP50 (P=0.021). Multivariate Cox regression analysis indicated that TSP50 overexpression was an independent prognostic factor for gastric cancer patients (P=0.017). Conclusions. Our data demonstrate that elevated TSP50 protein expression could be a potential predictor of poor prognosis in gastric cancer patients.
format Article
id doaj-art-d07267ead5994c4789b02c78a8feebd5
institution DOAJ
issn 1687-6121
1687-630X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-d07267ead5994c4789b02c78a8feebd52025-08-20T03:19:46ZengWileyGastroenterology Research and Practice1687-61211687-630X2014-01-01201410.1155/2014/498246498246Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric CancerFang Liu0Qinghua Cao1Ni Liu2Changzhao Li3Changxuan You4Chuanxin Liu5Ling Xue6Rongcheng Luo7Cancer Center, Southern Medical University, Guangzhou 510315, ChinaDepartment of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, ChinaDepartment of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, ChinaDepartment of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham, Birmingham, AL 35205, USADepartment of Medical Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, ChinaCancer Center, Southern Medical University, Guangzhou 510315, ChinaDepartment of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, ChinaCancer Center, Southern Medical University, Guangzhou 510315, ChinaPurpose. To investigate the expression of TSP50 protein in human gastric cancers and its correlation with clinical/prognostic significance. Methods. Immunohistochemistry (IHC) analysis of TSP50 was performed on a tissue microarray (TMA) containing 334 primary gastric cancers. Western blot was carried out to confirm the expression of TSP50 in gastric cancers. Results. IHC analysis revealed high expression of TSP50 in 57.2% human gastric cancer samples (191 out of 334). However, it was poorly expressed in all of the 20 adjacent nontumor tissues. This was confirmed by western blot, which showed significantly higher levels of TSP50 expression in gastric cancer tissues than adjacent nontumor tissues. A significant association was found between high levels of TSP50 and clinicopathological characteristics including junior age at surgery (P=0.001), later TNM stage (P=0.000), and present lymph node metastases (P=0.003). The survival of gastric cancer patients with high expression of TSP50 was significantly shorter than that of the patients with low levels of TSP50 (P=0.021). Multivariate Cox regression analysis indicated that TSP50 overexpression was an independent prognostic factor for gastric cancer patients (P=0.017). Conclusions. Our data demonstrate that elevated TSP50 protein expression could be a potential predictor of poor prognosis in gastric cancer patients.http://dx.doi.org/10.1155/2014/498246
spellingShingle Fang Liu
Qinghua Cao
Ni Liu
Changzhao Li
Changxuan You
Chuanxin Liu
Ling Xue
Rongcheng Luo
Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer
Gastroenterology Research and Practice
title Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer
title_full Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer
title_fullStr Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer
title_full_unstemmed Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer
title_short Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer
title_sort overexpression of testes specific protease 50 tsp50 predicts poor prognosis in patients with gastric cancer
url http://dx.doi.org/10.1155/2014/498246
work_keys_str_mv AT fangliu overexpressionoftestesspecificprotease50tsp50predictspoorprognosisinpatientswithgastriccancer
AT qinghuacao overexpressionoftestesspecificprotease50tsp50predictspoorprognosisinpatientswithgastriccancer
AT niliu overexpressionoftestesspecificprotease50tsp50predictspoorprognosisinpatientswithgastriccancer
AT changzhaoli overexpressionoftestesspecificprotease50tsp50predictspoorprognosisinpatientswithgastriccancer
AT changxuanyou overexpressionoftestesspecificprotease50tsp50predictspoorprognosisinpatientswithgastriccancer
AT chuanxinliu overexpressionoftestesspecificprotease50tsp50predictspoorprognosisinpatientswithgastriccancer
AT lingxue overexpressionoftestesspecificprotease50tsp50predictspoorprognosisinpatientswithgastriccancer
AT rongchengluo overexpressionoftestesspecificprotease50tsp50predictspoorprognosisinpatientswithgastriccancer